Sanofi Said to Be in Advanced Talks to Buy Drugmaker Actelion

didn’t immediately respond to requests for comment outside of normal business hours. Rare DiseasesParis-based Sanofi swooped in on Actelion after Johnson & Johnson abandoned talks to buy the company…

View this article online at Bloomberg
Source: Bloomberg – Paris Agreement

More news